PCV10 Reactogenicity and Immunogenicity Study - Malindi

NCT01028326 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Pneumococcal Pneumonia

Interventions

BIOLOGICAL: PCV10 and DTaP
BIOLOGICAL: PCV10 and DTaP
BIOLOGICAL: hepatitis A vaccine, DTaP, PCV10

Sponsor

KEMRI-Wellcome Trust Collaborative Research Program

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]